Research Paper Volume 12, Issue 23 pp 24228—24241
The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction
Figure 7. Gene set enrichment analyses. (A–C) Top 3 (HOXC6 target cancer, intestine probiotics, target of SMAD2 or SMAD3.) oncological signatures significantly C2 (hallmark gene sets) enriched in the high-risk group identified by gene set enrichment analysis. (D–F) Top 3 (nuclear periphery, apical junction assembly, nuclear matrix.) oncological signatures significantly C5 (biological process) enriched in the high-risk group identified by gene set enrichment analysis. (G–I) Top 3 (MTORC1 signaling, glycolysis, unfolded protein response.) oncological signatures significantly H (hallmark gene sets) enriched in the high-risk group identified by gene set enrichment analysis.